Background The objective of this study is to assess the impact of dysnatraemia on mortality among intensive care unit (ICU) patients in a large, international cohort.
Introduction
Serum sodium measurements are obtained routinely in intensive care unit (ICU) patients. Dysnatraemia (hyponatraemia and hypernatraemia) is common in these patients and has prognostic implications, such that sodium levels have been integrated into several severity scores [1] . Hyponatraemia is associated with worse outcomes, particularly in patients with congestive heart failure [2] and cirrhosis [3] . In a retrospective database of more than 150 000 ICU patients, Funk et al. [4] demonstrated that both hypo-and hypernatraemia present on admission to the ICU were independent risk factors for increased mortality. Patients were stratified into subgroups of hypo-and hypernatraemia (borderline, mild and severe), and even borderline dysnatraemia at admission to the ICU was an independent risk factor for poor prognosis. Recently, Whelan et al. [5] showed, in a cohort of more than 14 000 acute unselected (emergency) general medical patients, that serum sodium at admission was a risk factor for in-hospital mortality. Again, even borderline hyponatraemia (130-134 mM/L) was European Journal of Clinical Investigation Vol 43 933 DOI: 10.1111/eci.12123 ORIGINAL ARTICLE associated with a worse hospital outcome. Waikar et al. [6] also stratified a large population of unselected hospitalized adult patients according to the degree of hyponatraemia and showed a close relationship between hyponatraemia -even mild -and mortality. A limitation of their study was the evaluation of a cohort of patients over a 10-year period, during which significant changes in diagnosis and therapy may have occurred. In a prospective study conducted over a 14-year period, Darmon et al. [7] also observed that dysnatraemia was an independent risk factor for day-30 mortality. In a study of ICU-acquired dysnatraemia, Stelfox et al. [8] showed that ICUacquired hypo-and hypernatraemia were associated with increased hospital mortality, but these authors did not evaluate the relationship between the severity of the dysnatraemia and outcome.
We, therefore, used a large prospective database of ICU patients [9] to evaluate whether dysnatraemia is an independent risk factor for increased mortality in critically ill patients. We also investigated whether the presence of infection in these patients and the occurrence of dysnatraemia at ICU admission or during the ICU stay impacted on outcomes.
Patients and methods

Patient selection/database
The Extended Prevalence of Infection in Intensive Care (EPIC) II study protocol has been reported in detail previously [9] . ICUs were asked to participate in a 1-day, prospective, multicenter point prevalence study, conducted to provide an upto-date picture of the extent and pattern of infection in ICUs throughout the world (see Appendix A for list of participating ICUs). Demographic, physiological and therapeutic data were collected from all patients between midnight on May 7 and midnight on 8 May 2007. The Simplified Acute Physiology Score (SAPS) II was calculated on the study day. Data were recorded using preprinted case report forms. Participating ICUs were asked to provide patient follow-up until discharge or for 60 days (until 9 July 2007), and ICU and hospital outcomes were recorded. Participation in the EPIC II study was entirely voluntary, and the study was not funded. For the original EPIC II protocol, local ethical committee approval at each participating centre was expedited or waived owing to the purely observational nature of the study.
Definition of categories of patients
As part of SAPS II, serum sodium was measured in every patient on the study day (8 May 2007) ; in 25Á8% of the patients, this represented the day of ICU admission, and the remaining 74Á2% of patients were already being treated in the ICU. We analysed these subgroups of patients separately. Patients with normal sodium (135-145 mM/L) values represented the reference group. Dysnatraemia was divided into hyponatraemia (severe < 125 mM/L, moderate 125-129 mM/L and mild 130-134 mM/L) and hypernatraemia (mild 146-150 mM/L, moderate 151-155 mM/L and severe > 155 mM/L). The cutoffs used to divide dysnatraemia into categories were based on those previously used in the literature in order to be able to compare our results with previous reports [4, 6, 7] .
Infection was defined according to the definitions of the International Sepsis Forum [10] and adjudicated by the attending physician. To remove any bias of confounding variables for the association between dysnatraemia and mortality, a propensity score for each dysnatraemia class was estimated using multinomial logistic regression. The following variables were considered as factors: type of admission, source of admission, comorbidities, age, sex, mechanical ventilation, haemofiltration or haemodialysis, infection, SAPS II score and type of microorganism. After checking that balance on all covariates that were used in the propensity model had been achieved, we introduced the propensity score into the logistic regression model [11, 12] . Reported odds ratios were adjusted for propensity score, hospital and organizational related factors, including type of ICU (closed vs. open, community vs. university, surgical vs. medical), number of ICU beds, number of nurses, number of physiotherapists, presence of 24-h ICU physician coverage, length of ICU stay prior to study day and geographical region. Data are presented as mean (95% confidence interval), median [interquartile range (IQR)] or number (%) as appropriate. All tests were two tailed, and a P < 0Á05 was considered statistically significant. Table 1 Baseline patient characteristics and outcomes according to serum sodium level Table 1 . SAPS II and SOFA scores were significantly higher in patients with all degrees of dysnatraemia than in those with normal sodium levels. Hypernatraemia was more common than normonatraemia in mechanically ventilated patients. Patients with hypernatraemia and mild hyponatraemia had longer lengths of ICU stay prior to the study day than those with normonatraemia. Of the 13 276 measurements, 3425 (25Á8%) were made in patients who were admitted on the study day and 9851 (74Á2%) in patients who were already present in the ICU. In patients admitted on the study day, the prevalence of hyponatraemia (12Á3%) and hypernatraemia (12Á1%) was similar (P = 0Á81), whereas hypernatraemia was more frequent than hyponatraemia in patients already in the ICU (17Á1% vs. 13Á1%, P < 0Á001).
Statistical analysis
Na < 125 mM/L n =101 125 < Na ≤ 129 mM/L n = 253 130 < Na ≤ 134 mM/L n = 1359 Na normal (135-145 mM/L) n = 9461 146 < Na ≤ 150 mM/L n = 1411 151 < Na ≤ 155 mM/L n = 446 Na > 155 mM/L n = 245 Patient characteristics Age Mean 58Á6 6 1 Á6 6 0 Á1 6 0 Á7 6 1 Á9* 60Á9 5 8 Á6 95% CI 55Á4-61Á9 5 9 Á5-63Á7 5 9 Á1-61 60Á3-61 61Á1-62Á8 5 9 Á3-62Á4 5 6 Á3-60Á9 Male % 5 9 Á4 5 8 Á9 6 2 Á1 6 2 Á5 6 2 Á4 6 0 Á9 6 6 Á5 SAPS II Mean 48Á4* 38Á6* 35Á6* 33Á9 4 1 Á2* 45* 45Á9* 95% CI 44Á7-52 36Á5-40Á6 3 4 Á7-36Á4 3 3 Á6-34Á2 4 0 Á4-42 43Á4-46Á5 4 3 Á8-48 SOFA Mean 8Á5* 7Á2* 6Á3* 5Á9 7 Á5* 8Á5* 8Á9* 95% CI 6Á9-10 6Á5-7Á8 6 -6Á6 5 Á8-6 7 Á3-7Á8 8 -8Á9 8 Á4-9Á5
Relation with mortality and length of stay
There were significant differences in ICU and hospital lengths of stay among the groups of patients with dysnatraemia (P < 0Á001) ( Table 2 ). Hospital mortality rates for the different groups also differed (Table 2) , following a U-shaped pattern ( Fig. 1 ) with higher rates for severe dysnatraemia; hospital mortality reached more than 50% for patients with severe hypernatraemia. Hospital mortality rates were similar in patients with dysnatraemia already present in the ICU compared with those admitted on the study day both for hyponatraemia (28Á8% vs. 29Á3%) and hypernatraemia (39Á2% vs. 35Á3%). Adjusted ORs for hospital mortality also had a U shape with higher values at the extreme sodium values (Fig. 2) . The association between dysnatraemia and hospital mortality was observed in infected as well as in noninfected patients and was not statistically different between the two groups of patients (P = 0Á061) (Fig. 3) .
Discussion
In this study, we investigated the frequency of dysnatraemia and its effect on mortality in a large, mixed population of medical and surgical patients in 1265 ICUs across 76 countries. Dysnatraemia was common, affecting 29% of ICU patients, and was independently associated with increased hospital mortality.
The higher incidence of hypernatraemia in patients already being treated in the ICU (17Á1%) compared with newly admitted patients (12Á1%) is in accordance with the results of other series [13] [14] [15] . In a retrospective monocentre study, Lindner et al. [13] reported that the majority of cases of hypernatraemia (defined as a serum sodium > 149 mM/L) in the ICU developed during the ICU stay (2% hypernatraemia on admission vs. 7% during the ICU stay). These authors did not find a difference in mortality (39% vs. 43%) between the two subgroups. Using a similar cut-off of serum sodium (> 150 mM/L), the incidence of hypernatraemia in our database -defined as moderate to severe hypernatraemia according to our criteria -was 3Á6% at admission and 5Á7% during the ICU stay, and we also found no significant difference in mortality rates between these groups of patients (40Á0% vs. 49Á5%, P = 0Á27). In a French multicentre cohort, using the same cutoff value of 150 mM/L, hypernatraemia was observed in 3Á6% of patients at ICU admission and in 14Á7% of patients already treated in the ICU [14] . In a recent large cohort of ICU patients, Waite et al. [16] reported that hypernatraemia (defined as serum Na > 149 mM/L) developed after admission in 4Á3% of patients and was independently associated with an increased risk of hospital mortality [relative risk (RR) 1Á40 (95% confidence interval, 1Á34-1Á45)] and ICU length of stay. All these results suggest an iatrogenic component for the hypernatraemia occurring during the ICU stay. Some authors have suggested that the incidence of hypernatraemia in the ICU is an indicator of the quality of care [17] .
The mechanisms involved in the development of hypernatraemia during the ICU stay include sodium gain and/or loss Table 1 Continued of free water and can be discriminated by clinical assessment and urine electrolyte analysis [18] . Because many critically ill patients have impaired levels of consciousness, their water balance can no longer be regulated by thirst. This applies particularly to patients receiving mechanical ventilation, which was associated with more frequent development of hypernatraemia in our cohort. In a monocentre case-control study including 130 cases of hypernatraemia, Hoorn et al. [19] showed that hypernatraemia was more commonly associated with sepsis, hypokalaemia, renal dysfunction, hypoalbuminaemia and the use of mannitol and sodium bicarbonate (17) . Natraemia > 150 mM/L was associated with an almost fivefold increase in mortality rate (48% vs. 10%). Interestingly, fluid balance was positive in 38Á4% of patients. We were unable to estimate fluid balance in our database because, although 24-h urine output was collected on the study day, fluid intake was not collected. Data regarding the incidence and the prognostic value of hyponatraemia on admission compared with during the ICU stay are scarcer. In our series, the crude hospital mortality of patients with hyponatraemia was similar in the two groups. The difference in the incidence of hyponatraemia between newly admitted patients and patients already on the ICU (12Á3% vs 13Á1% respectively) was lower than for hypernatraemia (13Á1% vs. 17Á1%, respectively). In their study on the epidemiology of ICU-acquired dysnatraemia, Stelfox et al. [8] reported a higher incidence of ICU-acquired hypernatraemia (26%) than of ICU-acquired hyponatraemia (11%), but these authors included serum sodium values of 133 and 134 mM/L in their normal range. In contrast, using a threshold of 135 mM/L to define hyponatraemia, Sakr et al. [15] found a higher incidence of ICU-acquired hyponatraemia (13Á6%) than ICU-acquired hypernatraemia (9Á1%) in a series of about 11 000 surgical ICU patients. In our series, dysnatraemia observed in patients already in the ICU on the study day cannot be strictly considered as ICU-acquired dysnatraemia as the condition may has already been present prior to ICU admission. This represents a limitation to the comparison with other series and in particular that of Sakr et al. [15] , in which dysnatraemia at ICU admission was associated with a higher risk of in-hospital death, compared with ICU-acquired dysnatraemia. In our study, hospital mortality was not statistically different in patients with dysnatraemia admitted in the ICU on the study day than in those already present in the ICU on the study day, although there a was a tendency towards a lower mortality in this latter group.
Our study documented the U-shaped pattern of mortality described in earlier studies of ICU and non-ICU populations [4] [5] [6] [7] , with greater mortality rates at the extreme values of both hypo-and hypernatraemia. Interestingly, the only adjusted OR for hospital mortality that did not follow the U-shaped pattern 
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Admission: patients admitted on the study day; already in ICU: patients admitted to the ICU prior to the study day.
was that of patients already in the ICU who had severe hyponatraemia, an observation also made in the series by Funk et al. [4] . The association between dysnatraemia and mortality was present in infected and noninfected patients, but was not different between these groups. Waikar et al. [6] studied the influence of hyponatraemia on in-hospital, 1-year and 5-years mortality rates in a large population of more than 98 000 unselected adult patients. Although these authors observed a close relationship between hyponatraemia -even when mildand hospital mortality, mortality was not increased in patients with septic hyponatraemia, for any degree of hyponatraemia. However, their population was not an ICU cohort, which suggests a difference in the degree of severity of sepsis and organ dysfunctions. This study has several strengths and limitations. The EPIC II study was a multicentre worldwide cohort. The strength of a point prevalence study is to eliminate any variability in treatments that may occur over the years, as has been the case in some other studies [4, 7] . In particular, intravenous fluid dose and composition have changed over the years as individualized goal-directed fluid therapy has become more common [20] . The limitation of a point prevalence study is the lack of information about the time course of these abnormalities and factors that may have contributed to the development of dysnatraemia during the ICU stay. In addition, we did not collect data on therapeutic decisions likely to influence natraemia, such as the nature and amount of fluid administered or other forms of treatment, including diuretics or vasopressin derivatives. Another potential limitation is that the data were obtained several years ago; nevertheless, although there have been some changes in the overall management of critically ill patients during that time, the treatment of dysnatraemia has not changed much. Finally, the prognostic value of dysnatraemia in ICU patients does not necessarily imply a cause-and-effect relationship; rather dysnatraemia may be a surrogate marker for severity of underlying disease. Nevertheless, dysnatraemia and associated conditions probably act as additive mechanisms leading to death. This possible mechanism has also been suggested by Hoorn et al. [21] in a recent review on hyponatraemia and mortality: the underlying disease causes hyponatraemia and contributes to mortality, but hyponatraemia further increases this mortality risk.
In conclusion, we have shown that dysnatraemia in the ICU is an independent predictor of increased hospital mortality, whatever the degree of hypo-or hypernatraemia and whenever the dysnatraemia is recorded (at admission or during the ICU stay). There is a clear U-shaped relationship between the severity of the hypo-and hypernatraemia and mortality (in other words a 'dose-response effect'). This link between dysnatraemia and mortality supports the need for a prospective, controlled trial to investigate the impact of tight natraemic control on outcome. A challenge for such a trial would be to elaborate a therapeutic algorithm for the correction of dysnatraemia.
